New Haven, Connecticut
CNS clinical trials in New Haven, CT
41 CNS studies are recruiting participants at sites in New Haven as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
New Haven at a glance
- 41 studies are recruiting at a site in New Haven.
- By phase: Early Phase 1 (4), Phase 1 (5), Phase 2 (10), Phase 2/3 (1), Phase 3 (12), No phase (5), Observational (4). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (21), university, hospital or other (19), government (1).
- By research area: Depression (13), Parkinson's Disease (13), Epilepsy (5), Bipolar Disorder (3), Schizophrenia (3), Migraine (2), Multiple Sclerosis (2).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in New Haven
Basic details from each study's public record (the 30 most recently updated of 41). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Open-Label Psilocybin Study in Transdiagnostic Population
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Yale University
- Study site
- Connecticut Mental Health Center - Yale School of Medicine
- Registry record
- NCT06442423 · updated
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Phase 3
- Ages 18 to 85
- All sexes
- Sponsor
- Cybin IRL Limited
- Study site
- Yale School of Medicine - Yale Program for Psychedelic Science
- Registry record
- NCT06793397 · updated
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Yale University School of Medicine
- Registry record
- NCT07412756 · updated
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Yale Child Study Center
- Registry record
- NCT07227454 · updated
A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT07196501 · updated
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
- Phase 2
- Ages 40 to 80
- All sexes
- Sponsor
- Yale University
- Study site
- Yale University
- Registry record
- NCT07610369 · updated
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Yale University
- Study site
- Yale School of Medicine
- Registry record
- NCT06713616 · updated
The OBSERVE Protocol
- Observational
- All ages
- All sexes
- Sponsor
- Yale University
- Study site
- Yale School of Medicine
- Registry record
- NCT06725277 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in New Haven, CT on ClinicalTrials.gov.
Schizophrenia studies recruiting in New Haven
A Study of Brenipatide in Adult Participants With Schizophrenia
- Phase 2
- Ages 18 to 55
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Yale University School of Medicine
- Registry record
- NCT07410507 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in New Haven, CT on ClinicalTrials.gov.
Bipolar disorder studies recruiting in New Haven
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Yale University School of Medicine
- Registry record
- NCT07286175 · updated
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Yale New Haven Hospital-Smilow Cancer Center
- Registry record
- NCT06929273 · updated
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Connecticut Mental Health Center
- Registry record
- NCT06951698 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in New Haven, CT on ClinicalTrials.gov.
Parkinson's disease studies recruiting in New Haven
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Yale University School of Medicine ( Site 6009)
- Registry record
- NCT06952504 · updated
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Yale University School of Medicine ( Site 0201)
- Registry record
- NCT06623422 · updated
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Phase 3
- Ages 50 to 85
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Institute for Neurodegenerative Disorders
- Registry record
- NCT07174310 · updated
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Phase 2/3
- Ages 40 to 80
- All sexes
- Sponsor
- Biohaven Therapeutics Ltd.
- Registry record
- NCT06976268 · updated
MK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and [¹⁸F]MK-0947 in Participants With Parkinson's Disease (PD)
- Phase 1
- Ages 40 to 80
- All sexes
- Sponsor
- XingImaging, LLC
- Study site
- XingImaging, LLC
- Registry record
- NCT07880379 · updated
This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Michael J. Fox Foundation for Parkinson's Research
- Study site
- Institute for Neurodegenerative Disorders
- Registry record
- NCT07830654 · updated
A Comparative Performance Study Between High and Standard Resolution Positron Emission Tomography Camera Using [18F] AV-133 in Prodromal Parkinson's Disease
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Michael J. Fox Foundation for Parkinson's Research
- Study site
- Institute for Neurodegenerative Disorders
- Registry record
- NCT07809438 · updated
Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
- Phase 2
- Ages 45 to 85
- All sexes
- Sponsor
- Michael J. Fox Foundation for Parkinson's Research
- Study site
- Institute for Neurodegenerative Disorders / XingImaging, LLC
- Registry record
- NCT07020026 · updated
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Observational
- Ages 30 and older
- All sexes
- Sponsor
- Michael J. Fox Foundation for Parkinson's Research
- Study site
- Institute For Neurodegenerative Disorders
- Registry record
- NCT04477785 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in New Haven, CT on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in New Haven
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Smilow Cancer Center/Yale-New Haven Hospital · Yale University
- Registry record
- NCT03816345 · updated
Exploring the Utility of [18F]3F4AP for Demyelination Imaging
- Phase 1
- Ages 18 to 90
- All sexes
- Sponsor
- Yale University
- Study site
- Yale University PET Center
- Registry record
- NCT06999434 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in New Haven, CT on ClinicalTrials.gov.
Epilepsy studies recruiting in New Haven
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Phase 3
- Ages 2 and older
- All sexes
- Sponsor
- Epygenix
- Study site
- Yale School of Medicine - Yale-New Haven Hospital
- Registry record
- NCT04462770 · updated
Diagnosing Epilepsy To EffeCT Change
- No phase
- Ages 18 to 75
- All sexes
- Sponsor
- Epiminder America, Inc.
- Study site
- Yale School of Medicine
- Registry record
- NCT07110337 · updated
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
- Observational
- Ages 18 to 75
- All sexes
- Sponsor
- Epiminder America, Inc.
- Study site
- Yale School of Medicine
- Registry record
- NCT07110454 · updated
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Study site
- Yale University
- Registry record
- NCT06798896 · updated
Subcortical Arousal in Perceptual Awareness
- No phase
- Ages 13 and older
- All sexes
- Sponsor
- Yale University
- Study site
- Yale School of Medicine
- Registry record
- NCT06934356 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in New Haven, CT on ClinicalTrials.gov.
Migraine studies recruiting in New Haven
Study of EVO756 in Adults With Migraine
- Phase 2
- Ages 18 to 64
- All sexes
- Sponsor
- Evommune, Inc.
- Study site
- Hasbani Neurology
- Registry record
- NCT07616128 · updated
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- H. Lundbeck A/S
- Study site
- Yale School of Medicine - The Scirex Clinical Research Unit
- Registry record
- NCT05164172 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in New Haven, CT on ClinicalTrials.gov.
Ask about studies near New Haven
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections